Return to Library
Cardioversion Visual Overview
Topic

Cardioversion

💡 What You Need to Know

  • Procedure Overview: Cardioversion is a medical procedure that uses controlled electrical shocks or medications to restore a normal heart rhythm in individuals with certain types of arrhythmias.
  • Primary Goal: To convert an abnormal, rapid heart rhythm (like atrial fibrillation, atrial flutter, or ventricular tachycardia) back to a regular sinus rhythm.
  • Types of Cardioversion: Can be electrical (using a defibrillator to deliver a synchronized electrical shock) or pharmacological (using antiarrhythmic medications).
  • Indications: Often performed for symptomatic arrhythmias that are not resolving on their own or are causing hemodynamic instability.

🤒 Associated Symptoms

  • Palpitations: A sensation of a racing, pounding, or fluttering heart.
  • Shortness of Breath (Dyspnea): Difficulty breathing, especially with exertion or at rest.
  • Chest Discomfort: Pressure, tightness, or pain in the chest.
  • Dizziness or Lightheadedness: Feeling faint or unsteady.
  • Fatigue: Unusual tiredness or lack of energy.
  • Syncope or Presyncope: Fainting or feeling as if one is about to faint.
  • Reduced Exercise Tolerance: Inability to perform usual physical activities due to heart symptoms.

🛡 Crucial Precautions

  • Anticoagulation Therapy: For atrial fibrillation/flutter lasting more than 48 hours or of unknown duration, anticoagulation (blood thinners) is crucial for at least 3-4 weeks prior to and 4 weeks after cardioversion to prevent stroke.
  • NPO Status: Strict adherence to 'nothing by mouth' (NPO) guidelines for 6-8 hours before the procedure due to the need for sedation.
  • Electrolyte Balance: Pre-procedure assessment and correction of electrolyte imbalances (e.g., potassium, magnesium) to optimize success and minimize risks.
  • Pacemakers/ICDs: Inform the medical team if you have an implanted pacemaker or defibrillator, as specific precautions are needed to avoid device damage.
  • Pre-procedure TEE: A transesophageal echocardiogram (TEE) may be performed immediately before cardioversion if the duration of atrial fibrillation is uncertain or less than 3 weeks of anticoagulation has been achieved, to rule out intracardiac clots.

🍽 Dietary Directions & Restrictions

  • Pre-Procedure Fasting: Absolutely no food or drink (including water, gum, or candy) for at least 6-8 hours prior to the scheduled procedure due to the administration of sedatives.
  • Medication with Sips: Only essential medications may be taken with a very small sip of water, as instructed by your physician.
  • Post-Procedure Reintroduction: Once fully awake and alert, and your gag reflex has returned, you will typically be allowed to start with clear liquids, progressing to a light diet as tolerated.
  • Avoid Alcohol/Caffeine: Refrain from alcohol and excessive caffeine intake for at least 24 hours post-procedure, as these can irritate the heart and potentially trigger arrhythmias.

⚠️ Attendant Guidelines

  • Designated Driver: A responsible adult must be available to drive you home after the procedure due to the effects of sedation. Public transport or taxis are not permitted unless accompanied.
  • Post-Procedure Supervision: It is highly recommended to have an adult stay with you for at least 24 hours following cardioversion to monitor for any adverse effects of sedation or complications.
  • Activity Restrictions: Avoid driving, operating heavy machinery, making important decisions, or consuming alcohol for at least 24 hours post-procedure.
  • Report Symptoms: Immediately report any new or worsening symptoms such as chest pain, severe shortness of breath, dizziness, or recurrence of palpitations to your healthcare provider.

🩺 Physician's Perspective

  • Comprehensive Evaluation: A thorough pre-procedure assessment, including ECG, blood tests, and potentially an echocardiogram, is vital to determine suitability and minimize risks.
  • Risk-Benefit Discussion: Patients should have a clear understanding of the potential benefits (symptom relief, improved heart function) and risks (stroke, skin burns, arrhythmia recurrence) of cardioversion.
  • Anticoagulation Adherence: Emphasize the critical importance of strict adherence to prescribed anticoagulation regimens, both before and after the procedure, to prevent thromboembolic events.
  • Lifestyle Modifications: Discuss the role of managing underlying conditions (e.g., hypertension, diabetes), weight control, and avoiding triggers (e.g., excessive alcohol, caffeine) in maintaining sinus rhythm post-cardioversion.

🎓 Academic & Nursing Corner

  • Pre-Procedure Checklist: Ensure informed consent is signed, NPO status is confirmed, IV access is established, baseline vital signs and rhythm strip are obtained, and all necessary medications (especially anticoagulants) are reviewed.
  • Intra-Procedure Monitoring: Continuous cardiac monitoring, pulse oximetry, blood pressure, and respiratory rate are essential. Be prepared to assist with sedation administration and airway management.
  • Defibrillator Setup: Verify proper placement of defibrillator pads, ensure synchronization mode is activated for electrical cardioversion, and confirm appropriate energy settings.
  • Post-Procedure Care: Monitor vital signs and cardiac rhythm closely, assess level of consciousness, ensure airway patency, check skin integrity under pads, and provide clear discharge instructions.
  • Patient Education: Educate the patient and family on signs of complications, medication adherence (especially anticoagulants), activity restrictions, and follow-up appointments.

🔬 Clinical Reference Index

  • Synchronization: Electrical cardioversion must be synchronized with the R-wave of the QRS complex to avoid delivering a shock during the vulnerable T-wave (R-on-T phenomenon), which can induce ventricular fibrillation.
  • Energy Levels: Initial energy settings vary based on the type of arrhythmia and patient factors; typically 50-100 Joules for atrial flutter/SVT and 100-200 Joules for atrial fibrillation, escalating if needed.
  • Pharmacological Agents: Common antiarrhythmic drugs used for pharmacological cardioversion include amiodarone, flecainide, propafenone, and ibutilide.
  • Contraindications: Absolute contraindications include digitalis toxicity (due to increased risk of ventricular arrhythmias) and non-sustained ventricular tachycardia (unless hemodynamically unstable).
  • Sedation: Short-acting sedatives (e.g., propofol, etomidate, midazolam) are used to ensure patient comfort and amnesia during the brief, painful electrical shock.